US 8901171
Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
granted A61KA61K31/216A61K31/235
Quick answer
US patent 8901171 (Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent) held by Takeda Pharmaceutical Company Limited expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/216, A61K31/235, A61K31/282, A61K31/337